cytokines that don't provide a proper
anti-tumor immune response, but initiate formation and growth of new
Li, Xiang,
Yin, Lina,
Liao, Jing,
Yang, Jun,
Cai, Binhao,
Yu, Yiming,
Su, Sijia,
Du, Zhiteng,
Li, Xiaobo,
Zhou, Ying,
Chen, Pan,
Cho, Won-Jea,
Chattipakorn, Nipon,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhang, Fengzhi,
Liang, Guang,
Tang, Qidong (2023) and synthesized using cinnamic acid as the lead compound. We tested the preliminary
anti-inflammatory
activityLuo, W.,
Chen, X.,
Ye, L.,
Chen, X.,
Jia, W.,
Zhao, Y.,
Samorodov, A.V.,
Zhang, Y.,
Hu, X.,
Zhuang, F.,
Qian, J.,
Zheng, C.,
Liang, G.,
Wang, Y. (2021) rhizome, with
anti-oxidant/anti-inflammatory effects demonstrated in various disease models, including
of
activating the immune response against tumor cells. Clinically used checkpoint inhibition using antibodies